How many drugs treat Enterococcus Complicated UTI?

Drug Landscape tracks 5 marketed treatments for Enterococcus Complicated UTI (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/enterococcus-complicated-uti.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Enterococcus Complicated UTI — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enterococcus Complicated UTI (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Enterococcus Complicated UTI, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Cystadane	BETAINE	Recordati	Methylating Agent [EPC]		1996-01-01
Cipro	ciprofloxacin	Bayer AG	Fluoroquinolone antibiotic	DNA topoisomerase II, DNA gyrase subunit A, DNA gyrase subunit A	1987-10-22
Cystadane	Cystadane	Mayo Clinic
Ofloxacine	Ofloxacine	Assistance Publique - Hôpitaux de Paris		Gamma-aminobutyric acid receptor subunit alpha-2, Histamine H3 receptor, Muscarinic acetylcholine receptor M1
Ciprofloxacine	Ciprofloxacine	Poitiers University Hospital		DNA topoisomerase II, DNA gyrase subunit A, DNA gyrase subunit A

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 3 drugs in Enterococcus Complicated UTI
Assistance Publique - Hôpitaux de Paris · 1 drug in Enterococcus Complicated UTI
Bayer AG · 1 drug in Enterococcus Complicated UTI
Mayo Clinic · 1 drug in Enterococcus Complicated UTI
Poitiers University Hospital · 1 drug in Enterococcus Complicated UTI
Recordati · 1 drug in Enterococcus Complicated UTI

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Enterococcus Complicated UTI:

Cite this brief

Drug Landscape (2026). Enterococcus Complicated UTI — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/enterococcus-complicated-uti. Accessed 2026-06-10.

Enterococcus Complicated UTI full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing